These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 35086435)

  • 21. Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia.
    Mansour W; Haenni M; Saras E; Grami R; Mani Y; Ben Haj Khalifa A; El Atrouss S; Kheder M; Fekih Hassen M; Boujâafar N; Bouallegue O; Madec JY
    J Glob Antimicrob Resist; 2017 Sep; 10():88-94. PubMed ID: 28711559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China.
    Hu H; Shi Q; Zhang P; Quan J; Han X; Zhao D; Zhang H; Wang Q; Jiang Y; Yu Y
    Int J Antimicrob Agents; 2023 Aug; 62(2):106873. PubMed ID: 37276893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phylogenomic approach for the analysis of colistin resistance-associated genes in Klebsiella pneumoniae, its mutational diversity and implications for phenotypic resistance.
    Elias R; Spadar A; Phelan J; Melo-Cristino J; Lito L; Pinto M; Gonçalves L; Campino S; Clark TG; Duarte A; Perdigão J
    Int J Antimicrob Agents; 2022 Jun; 59(6):106581. PubMed ID: 35378228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.
    Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.
    Wand ME; Bock LJ; Bonney LC; Sutton JM
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of colistin-resistant Klebsiella pneumoniae in Poland.
    Sękowska A; Chudy M; Gospodarek-Komkowska E
    Acta Microbiol Immunol Hung; 2019 Dec; 67(1):18-22. PubMed ID: 31813256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathways Regulating the pbgP Operon and Colistin Resistance in Klebsiella pneumoniae Strains.
    Choi MJ; Kim S; Ko KS
    J Microbiol Biotechnol; 2016 Sep; 26(9):1620-8. PubMed ID: 27238937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colistin- and Carbapenem-Resistant Klebsiella pneumoniae Clinical_Isolates: Algeria.
    Yousfi H; Hadjadj L; Dandachi I; Lalaoui R; Merah A; Amoura K; Dahi A; Dekhil M; Messalhi N; Diene SM; Baron S; Rolain JM
    Microb Drug Resist; 2019 Mar; 25(2):258-263. PubMed ID: 30256174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy.
    Shein AMS; Wannigama DL; Higgins PG; Hurst C; Abe S; Hongsing P; Chantaravisoot N; Saethang T; Luk-In S; Liao T; Nilgate S; Rirerm U; Kueakulpattana N; Srisakul S; Aryukarn A; Laowansiri M; Hao LY; Yonpiam M; Ragupathi NKD; Techawiwattanaboon T; Ngamwongsatit N; Amarasiri M; Ounjai P; Kupwiwat R; Phattharapornjaroen P; Badavath VN; Leelahavanichkul A; Kicic A; Chatsuwan T
    Sci Rep; 2022 Jul; 12(1):12939. PubMed ID: 35902639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin-resistant Klebsiella pneumoniae bloodstream infection: old drug, bad bug.
    Ben-Chetrit E; Mc Gann P; Maybank R; Stam J; Assous MV; Katz DE
    Arch Microbiol; 2021 Aug; 203(6):2999-3006. PubMed ID: 33774687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.
    Zhu Y; Galani I; Karaiskos I; Lu J; Aye SM; Huang J; Yu HH; Velkov T; Giamarellou H; Li J
    J Infect; 2019 Oct; 79(4):312-321. PubMed ID: 31374222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and epidemiological surveillance of polymyxin-resistant Klebsiella pneumoniae strains isolated from Brazil with multiple mgrB gene mutations.
    da Silva KE; Thi Nguyen TN; Boinett CJ; Baker S; Simionatto S
    Int J Med Microbiol; 2020 Oct; 310(7):151448. PubMed ID: 33092694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of colistin-resistant Enterobacteriaceae in inpatient and avian isolates from China: high prevalence of mcr-negative Klebsiella pneumoniae.
    Wang X; Liu Y; Qi X; Wang R; Jin L; Zhao M; Zhang Y; Wang Q; Chen H; Wang H
    Int J Antimicrob Agents; 2017 Oct; 50(4):536-541. PubMed ID: 28668693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colistin resistance due to insertional inactivation of the mgrB in Klebsiella pneumoniae of clinical origin: First report from India.
    Kumar A; Biswas L; Omgy N; Mohan K; Vinod V; Sajeev A; Nair P; Singh S; Biswas R
    Rev Esp Quimioter; 2018 Oct; 31(5):406-410. PubMed ID: 30221899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A putative RND-type efflux pump, H239_3064, contributes to colistin resistance through CrrB in Klebsiella pneumoniae.
    Cheng YH; Lin TL; Lin YT; Wang JT
    J Antimicrob Chemother; 2018 Jun; 73(6):1509-1516. PubMed ID: 29506266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance evolution of hypervirulent carbapenem-resistant
    Jin X; Chen Q; Shen F; Jiang Y; Wu X; Hua X; Fu Y; Yu Y
    Emerg Microbes Infect; 2021 Dec; 10(1):1129-1136. PubMed ID: 34074225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of colistin-resistant
    Shankar C; Venkatesan M; Rajan R; Mani D; Lal B; Prakash JAJ; Anandan S; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B
    Indian J Med Res; 2019 Feb; 149(2):199-207. PubMed ID: 31219084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colistin Resistance and Extensive Genetic Variations in PmrAB and PhoPQ in Klebsiella Pneumoniae Isolates from South Korea.
    Cheong HS; Kim SY; Seo J; Wi YM; Peck KR; Ko KS
    Curr Microbiol; 2020 Sep; 77(9):2307-2311. PubMed ID: 32524274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mcr-1 Gene Has No Effect on Colistin Resistance When It Coexists with Inactivated mgrB Gene in Klebsiella pneumoniae.
    Zhang H; Zhao D; Shi Q; Quan J; Li X; Yu Y
    Microb Drug Resist; 2018 Oct; 24(8):1117-1120. PubMed ID: 29768099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.
    Cannatelli A; D'Andrea MM; Giani T; Di Pilato V; Arena F; Ambretti S; Gaibani P; Rossolini GM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5521-6. PubMed ID: 23979739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.